Page last updated: 2024-08-26

tretazicar and B16 Melanoma

tretazicar has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benouchan, M; Colombo, BM; Do Nascimento, F; Perret, GY1

Other Studies

1 other study(ies) available for tretazicar and B16 Melanoma

ArticleYear
Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms.
    International journal of oncology, 2006, Volume: 28, Issue:2

    Topics: Animals; Antineoplastic Agents; Aziridines; Bystander Effect; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Endothelium, Vascular; Escherichia coli; Genetic Therapy; Humans; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroreductases; Prodrugs; Transfection

2006